How to Sign Up for Join Luma

Gather your current height and weight, a complete medication and supplement list, allergies, relevant diagnoses and prior weight-management treatment. Include prescription medicines, nonprescription products and any other GLP-1 medication. If you already use one, write down its name, dose in milligrams, formulation and last dose date.

Use a current prescription label rather than relying on memory. Tell the clinician about previous nausea, vomiting, constipation or treatment interruptions, not just whether the medication helped your appetite. A clear history helps the clinician assess safety and reduces the need to reconstruct important details later. See how to prepare before starting a GLP-1 for a practical checklist.

Visit intake.joinluma.com to begin the online health questions. Enter accurate information about your health history, goals, current medicines and treatment experience. Do not leave out a condition because you think it might affect eligibility: the clinician needs the full picture to make a useful decision.

Describe pregnancy, pregnancy plans, breastfeeding, a history of pancreatitis, serious stomach-emptying problems, and personal or family history of medullary thyroid carcinoma or MEN2. These issues may change whether or how treatment is considered. If you are unsure of a diagnosis or medication strength, check your records rather than guessing. Submitting an intake requests medical assessment; it does not guarantee a prescription.

You can express a preference for compounded semaglutide or compounded tirzepatide and choose a formulation and plan for clinical review. Weekly injections and once-daily dissolving oral ODT tablets are different treatment formats; they are not interchangeable dose for dose. The clinician confirms what is appropriate for your history and needs.

Review weekly injection options and oral ODT options before selecting. Oral ODT tablets are compounded and built in with ondansetron for anti-nausea support; that does not guarantee you will have no nausea.

Medical care is provided by Arora Health and Aesthetics. A licensed clinician reviews every intake before anything is prescribed and may need additional information before deciding. Join Luma does not promise that submitting a questionnaire means approval, and this guide does not promise a particular review turnaround.

The clinician evaluates your health history, current medicines and whether the proposed treatment is appropriate. You are charged only if the clinician approves treatment. Keep medical approval separate from plan selection: choosing a medication or payment option is not the same as receiving a prescription. If the clinician asks a follow-up question, answer with the same care you gave the initial intake.

New patients starting a three-month plan pay $99/month for compounded semaglutide or $149/month for compounded tirzepatide. This starting price applies to the first plan period and is designed to help people new to GLP-1 medication get started. Plans then renew at affordable Current GLP User pricing for the same commitment length: $119/month for semaglutide or $179/month for tirzepatide on three-month plans.

Plans include clinician oversight, medication if prescribed, necessary supplies and shipping, with no membership fees. The price stays the same at every dose within your plan; a prescribed increase does not itself raise that price. That is different from renewal pricing or moving to a different medication or commitment length.

Check the current plan and pricing details before submitting. If you compare monthly equivalents, also check the billing period and total commitment so you understand what you are selecting. Ask support about any billing detail that is unclear rather than assuming a monthly equivalent means monthly billing.

Pharmacy routing depends on the formulation and your state. Hallandale Pharmacy prepares the additive-free formulation. VialsRx Pharmacy prepares formulations with glycine or vitamin B12. Both are U.S.-licensed 503A compounding pharmacies; your clinician confirms the formulation rather than treating a pharmacy preference as a prescription.

Hallandale does not ship to Alabama, Arkansas, California, Hawaii, Kansas, Massachusetts, Michigan, Minnesota or Mississippi. In those states, VialsRx is the Join Luma pharmacy option. VialsRx ships to all 50 states. Free expedited 2-day shipping begins once medication is dispensed, not when you first submit intake. Keep review, dispensing and transit as separate stages when planning your start.

When your package arrives, check the patient name, medication, pharmacy, concentration, directions and beyond-use date. Follow the dispensing pharmacy’s storage instructions. If the package arrives warm, do not throw it away: put it in the fridge and contact Join Luma for guidance before using it.

The FDA’s dosing-error alert describes mistakes involving different concentrations and confusion between milligrams, milliliters and syringe units. Read the label on each new vial, even when the medication name looks familiar. Ask the clinician or dispensing pharmacy to confirm any measurement you cannot confidently explain back.

Read the first-injection guide if you are prescribed injections. Have the right supplies and understand the prescribed amount before opening or drawing from a vial. Do not substitute instructions from an old prescription, a social-media demonstration or a brand-name pen for your current label.

Support is available 24/7 at support@joinluma.com or through the patient portal; most inquiries receive a reply within 1–2 hours. That is a typical support response window, not a guarantee of clinician review or an emergency service. Ask support to help route medical questions to your clinician rather than treating a billing reply as dosing authorization.

Seek urgent care for severe abdominal pain, signs of pancreatitis, significant dehydration, or a serious allergic reaction; call 911 for a life-threatening emergency. Do not wait for a portal reply in an emergency. For nonurgent nausea, constipation, appetite changes or uncertainty about the next dose, contact your clinician for a plan tailored to your symptoms.

The FDA explains what compounded status means. Compounded medications are not the FDA-approved Wegovy or Zepbound products, and brand-product trial results are not promises about your compounded prescription. Your clinician can help explain the treatment choice and what to monitor as care continues.